Crossref
Neurofeedback Requires Better Evidence of Efficacy Before It Should Be Considered a Legitimate Treatment for ADHD: What is the Evidence for this Claim?
NeuroRegulation · 2014
DOI: 10.15540/nr.1.1.25 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroRegulation, 2014. Verfasst von H. Edmund Pigott und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pigott, H. E., & Cannon, R. (2014). Neurofeedback Requires Better Evidence of Efficacy Before It Should Be Considered a Legitimate Treatment for ADHD: What is the Evidence for this Claim?. NeuroRegulation. https://doi.org/10.15540/nr.1.1.25
Vancouver
Pigott HE, Cannon R. Neurofeedback Requires Better Evidence of Efficacy Before It Should Be Considered a Legitimate Treatment for ADHD: What is the Evidence for this Claim?. NeuroRegulation. 2014. doi:10.15540/nr.1.1.25
BibTeX
@article{Pigott2014,
author = {Pigott, H. Edmund and Cannon, Rex},
title = {Neurofeedback Requires Better Evidence of Efficacy Before It Should Be Considered a Legitimate Treatment for ADHD: What is the Evidence for this Claim?},
journal = {NeuroRegulation},
year = {2014},
doi = {10.15540/nr.1.1.25}
}
EUVIMED